Korro Bio, Inc. (KRRO) vs Unicycive Therapeutics, Inc. (UNCY)

Korro Bio, Inc. and Unicycive Therapeutics, Inc. are both Biotechnology companies. Korro Bio, Inc. and Unicycive Therapeutics, Inc. are of similar size ($140.9M and $134.0M). Across the 9 metrics below, Korro Bio, Inc. leads on 6 and Unicycive Therapeutics, Inc. on 3.

Valuation

Metric KRRO UNCY Biotechnology median
P/E n/m n/m 7.88
P/S 26.38 n/m 11.47
P/B 1.63 2.38 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 12.73 n/m 10.73
Earnings yield (104.49%) (37.15%) (28.84%)
Free cash flow yield (40.49%) (21.97%) (23.03%)

Profitability

Metric KRRO UNCY Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (97.69%) (101.07%) (57.72%)
Return on assets (62.03%) (69.05%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KRRO UNCY Biotechnology median
Revenue growth (TTM) (81.87%) — 5.64%
EPS growth (last fiscal year) (33.19%) 70.18% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KRRO UNCY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.55 3.81 4.73
Net debt to EBITDA 0.64 1.43 0.96

Dividend

Metric KRRO UNCY Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric KRRO UNCY Biotechnology median
Market cap 140.92m 133.98m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack